PHILADELPHIA — David Artis, PhD, assistant professor of Microbiology at the Perelman School of Medicine, University of Pennsylvania, will receive the AAI-BD Biosciences Investigator Award for outstanding, early-career research contributions to the field of immunology from the American Association of Immunologists (AAI).
He is one of the recipients of an AAI award for outstanding research and career achievements to be conferred at IMMUNOLOGY 2013™, the AAI Centennial Meeting, May 3-7 in Honolulu, Hawaii.
Artis’s research is focused on understanding the regulatory mechanisms that control immune cell homeostasis at the body’s barrier surfaces. Employing diverse models of microbial colonization, pathogen infection and chronic inflammation, his research examines how mammalian host genetics and signals derived from commensal microbial communities influence innate and adaptive immune responses in the skin, lung, and intestine.
“It’s an enormous honor to be recognized by the members of the AAI with such a prestigious award,” says Artis. “I also thank all the trainees and collaborators that I have had the pleasure of working with. An award like this is a testament to their creativity, hard-work, and dedication.”
Artis has also received the Lady Barbara Colyton Prize for Autoimmune Research in 2011 and the Stanley N. Cohen Biomedical Research Award from Penn in 2012, among other awards.
Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, excellence in patient care, and community service. The organization consists of the University of Pennsylvania Health System and Penn’s Raymond and Ruth Perelman School of Medicine, founded in 1765 as the nation’s first medical school.
The Perelman School of Medicine is consistently among the nation's top recipients of funding from the National Institutes of Health, with $550 million awarded in the 2022 fiscal year. Home to a proud history of “firsts” in medicine, Penn Medicine teams have pioneered discoveries and innovations that have shaped modern medicine, including recent breakthroughs such as CAR T cell therapy for cancer and the mRNA technology used in COVID-19 vaccines.
The University of Pennsylvania Health System’s patient care facilities stretch from the Susquehanna River in Pennsylvania to the New Jersey shore. These include the Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center, Chester County Hospital, Lancaster General Health, Penn Medicine Princeton Health, and Pennsylvania Hospital—the nation’s first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Medicine at Home, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.
Penn Medicine is an $11.1 billion enterprise powered by more than 49,000 talented faculty and staff.